117 related articles for article (PubMed ID: 2249997)
41. Binding of coagulation factor IXa to procoagulant platelets revisited: Low affinity and interactions with other factors.
Soloveva PA; Podoplelova NA; Panteleev MA
Biochem Biophys Res Commun; 2024 Aug; 720():150099. PubMed ID: 38749192
[TBL] [Abstract][Full Text] [Related]
42. Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages.
McGee MP; Li LC
J Biol Chem; 1991 May; 266(13):8079-85. PubMed ID: 1902470
[TBL] [Abstract][Full Text] [Related]
43. Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.
London FS; Walsh PN
Biochemistry; 2000 Aug; 39(32):9850-8. PubMed ID: 10933803
[TBL] [Abstract][Full Text] [Related]
44. The factor IXa second epidermal growth factor (EGF2) domain mediates platelet binding and assembly of the factor X activating complex.
Wilkinson FH; Ahmad SS; Walsh PN
J Biol Chem; 2002 Feb; 277(8):5734-41. PubMed ID: 11714704
[TBL] [Abstract][Full Text] [Related]
45. Exosite binding drives substrate affinity for the activation of coagulation factor X by the intrinsic Xase complex.
Basavaraj MG; Krishnaswamy S
J Biol Chem; 2020 Nov; 295(45):15198-15207. PubMed ID: 32859749
[TBL] [Abstract][Full Text] [Related]
46. The role of phospholipid and factor VIIIa in the activation of bovine factor X.
van Dieijen G; Tans G; Rosing J; Hemker HC
J Biol Chem; 1981 Apr; 256(7):3433-42. PubMed ID: 6782101
[TBL] [Abstract][Full Text] [Related]
47. The gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IXa beta. Effects on the serine protease module and factor X activation.
Astermark J; Hogg PJ; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3682-9. PubMed ID: 8106413
[TBL] [Abstract][Full Text] [Related]
48. Partial activation of the factor VIIIa-factor IXa enzyme complex by dihexanoic phosphatidylserine at submicellar concentrations.
Gilbert GE; Arena AA
Biochemistry; 1997 Sep; 36(35):10768-76. PubMed ID: 9271508
[TBL] [Abstract][Full Text] [Related]
49. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme.
Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466
[TBL] [Abstract][Full Text] [Related]
50. PAR-1-stimulated factor IXa binding to a small platelet subpopulation requires a pronounced and sustained increase of cytoplasmic calcium.
London FS; Marcinkiewicz M; Walsh PN
Biochemistry; 2006 Jun; 45(23):7289-98. PubMed ID: 16752917
[TBL] [Abstract][Full Text] [Related]
51. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X.
Stern DM; Nawroth PP; Kisiel W; Vehar G; Esmon CT
J Biol Chem; 1985 Jun; 260(11):6717-22. PubMed ID: 3922979
[TBL] [Abstract][Full Text] [Related]
52. Kinetic comparison of bovine blood coagulation factors IXa alpha and IXa beta toward bovine factor X.
Link RP; Castellino FJ
Biochemistry; 1983 Aug; 22(17):4033-41. PubMed ID: 6412750
[TBL] [Abstract][Full Text] [Related]
53. Surface loop 199-204 in blood coagulation factor IX is a cofactor-dependent site involved in macromolecular substrate interaction.
Kolkman JA; Christophe OD; Lenting PJ; Mertens K
J Biol Chem; 1999 Oct; 274(41):29087-93. PubMed ID: 10506162
[TBL] [Abstract][Full Text] [Related]
54. Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase.
O'Brien LM; Mastri M; Fay PJ
Blood; 2000 Mar; 95(5):1714-20. PubMed ID: 10688829
[TBL] [Abstract][Full Text] [Related]
55. The kinetic assembly of the intrinsic bovine factor X activation system.
Beals JM; Chibber BA; Castellino FJ
Arch Biochem Biophys; 1989 Feb; 268(2):485-501. PubMed ID: 2492418
[TBL] [Abstract][Full Text] [Related]
56. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
[TBL] [Abstract][Full Text] [Related]
57. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism.
Sheehan JP; Phan TM
Biochemistry; 2001 Apr; 40(16):4980-9. PubMed ID: 11305914
[TBL] [Abstract][Full Text] [Related]
58. The influence of sodium ion binding on factor IXa activity.
Gopalakrishna K; Rezaie AR
Thromb Haemost; 2006 Jun; 95(6):936-41. PubMed ID: 16732371
[TBL] [Abstract][Full Text] [Related]
59. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa.
Jones ME; Griffith MJ; Monroe DM; Roberts HR; Lentz BR
Biochemistry; 1985 Dec; 24(27):8064-9. PubMed ID: 3879187
[TBL] [Abstract][Full Text] [Related]
60. Factor IXa:factor VIIIa interaction. helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa.
Bajaj SP; Schmidt AE; Mathur A; Padmanabhan K; Zhong D; Mastri M; Fay PJ
J Biol Chem; 2001 May; 276(19):16302-9. PubMed ID: 11278963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
